Across TCGA pan-cancer cohorts, CFAP57 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated CFAP57 data layer compared with 8 for mutation status and 2 for mass-spec protein.
The strongest signal is observed in uveal melanoma (UVM), where higher CFAP57 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CFAP57 expression acts as an unfavorable survival marker, although some lineages such as UVM and BRCA show a favorable association.
UVM, BRCA, and LGG are the cancer types where CFAP57 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.